Dr Rosalind Foster

Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J, 2018, 'Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial', BMC Public Health, vol. 18, http://dx.doi.org/10.1186/s12889-017-5018-9

Vaccher SJ; Gianacas C; Templeton DJ; Poynten IM; Haire BG; Ooi C; Foster R; McNulty A; Grulich AE; Zablotska IB, 2017, 'Baseline preferences for daily, event-driven, or periodic hiv pre-exposure prophylaxis among gay and bisexual men in the prelude demonstration project', Frontiers in Public Health, vol. 5, http://dx.doi.org/10.3389/fpubh.2017.00341

Vaccher SJ; Grulich AE; Haire BG; Conway DP; Poynten IM; Ooi C; Foster R; Templeton DJ; Zablotska IB, 2017, 'Validation of participant eligibility for preexposure prophylaxis: Baseline data from the PRELUDE demonstration project', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0185398

McAllister JW; Towns JM; McNulty A; Pierce AB; Foster R; Richardson R; Carr A, 2017, 'Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual men', AIDS, vol. 31, pp. 1291 - 1295, http://dx.doi.org/10.1097/QAD.0000000000001447

Mason E; Foster R; Wray L; McNulty A; Donovan B, 2016, 'Reactive arthritis following a Microsporidia infection', International Journal of STD and AIDS, vol. 27, pp. 1239 - 1241, http://dx.doi.org/10.1177/0956462416640364

Mulhall BP; Wright ST; De La Mata N; Allen D; Brown K; Dickson B; Grotowski M; Jackson E; Petoumenos K; Foster R, 2016, 'Risk factors associated with incident sexually transmitted infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study', HIV Medicine, vol. 17, pp. 623 - 630, http://dx.doi.org/10.1111/hiv.12371

Mason E; Wray L; Foster R; Jamil MS; Guy R; McNulty A; Donovan B, 2016, 'Reactive arthritis at the Sydney Sexual Health Centre 1992–2012: declining despite increasing chlamydia diagnoses', International Journal of STD and AIDS, vol. 27, pp. 882 - 889, http://dx.doi.org/10.1177/0956462415598251

Foster R; Ali H; Crowley M; Dyer R; Grant K; Lenton J; Little C; Knight V; Read P; Donovan B, 2016, 'Does Living Outside of a Major City Impact on the Timeliness of Chlamydia Treatment? A Multicenter Cross-Sectional Analysis', Sexually Transmitted Diseases, vol. 43, pp. 506 - 512, http://dx.doi.org/10.1097/OLQ.0000000000000496

Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I, 2016, 'Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE', BMJ Open, vol. 6, http://dx.doi.org/10.1136/bmjopen-2016-012179

Foster R; McAllister J; Read TR; Pierce AB; Richardson R; McNulty A; Carr A, 2015, 'Single-Tablet Emtricitabine-Rilpivirine-Tenofovir as HIV Postexposure Prophylaxis in Men Who Have Sex with Men', Clinical Infectious Diseases, vol. 61, pp. 1336 - 1341, http://dx.doi.org/10.1093/cid/civ511

Templeton DJ; Wright ST; McManus H; Lawrence C; Russell DB; Law MG; Petoumenos K; Ellis D; Bloch M; Agrawal S, 2015, 'Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD)', BMC Infectious Diseases, vol. 15, http://dx.doi.org/10.1186/s12879-015-1051-4

Gundevia Z; Foster R; Jamil MS; McNulty A, 2015, 'Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: Follow-up of a clinical cohort', Sexually Transmitted Infections, vol. 91, pp. 11 - 13, http://dx.doi.org/10.1136/sextrans-2014-051616

Foster R; Morris S; Ryder N; Wray L; McNulty A, 2011, 'Screening of HIV-infected patients for non-AIDS-related morbidity: An evidence-based model of practice', Sexual Health, vol. 8, pp. 30 - 42, http://dx.doi.org/10.1071/SH10021